2nd ETS: Allergy and Clinical Immunology Scientific Meeting, March 11 – 12, 2022
The Scientific Meeting ‘Allergy and Clinical Immunology’, supported by Novartis, was the 2nd chapter of a series of meetings will be held in 2022 in United Arab Emirates.
The sessions helped the 981 attendees from 39 countries around the world to know more about the developments in the field of Pediatric Pulmonology, understand the current trends in diagnosis and medication, and earn 10 CME hours.
Prof. Ashraf Alzaabi, president of Emirates Thoracic Society and the Chief of Medicine at Zayed Military Hospital in Abu Dhabi, has appointed Prof. Mohamed Abuzakouk, President of Allergy And Clinical Immunity Group, Staff Physician, Allergy ＆ Immunology at Cleveland Clinic Abu Dhabi, UAE, as the Chairman. Prof. Abuzakouk has welcomed all the attendees and officially introduced the eminent moderators Dr. Emad Arafa, Allergy, Immunology, and Pulmonology Specialist, and Head of the Allergy Department, NMC Specialty Hospital, Dubai, UAE, and Dr. Stuart Carr, Allergist & Clinical Immunologist, Canada, and CMO at Snö Asthma & Allergy, Abu Dhabi, UAE.
Dr. Emad explained the day-one agenda, and he introduced the speakers, Prof. Yaser K. Rashed, Professor of Pediatric Hepatology, Gastroenterology and GI Endoscopy, NLI, Egypt, and Consultant, Al Qassimi Woman and Children Hospital, Sharjah, UAE, Dr. Ravi Gutta, Division Chief & Consultant Allergy & Immunology, Mediclinic City Hospital, and Clinical Associate Professor (Adjunct), Mohamed Bin Rashid University, Dubai, UAE.
Dr. Ahmed Elghoudi focused on Oral – Food Pollen Syndrome “The Scratchy Mouth and Itchy Throat”. The lecture began with a quiz, to answer it he explained the difference between PFAS and true food allergy, and he mentioned that the treatments for PFAS should be individualized for patients because it can cause a wide range of symptoms from mild allergy to severe anaphylaxis in rare occasions.
AProf. Yaser’s lecture was centered on Gastrointestinal Presentations of Cow Milk Protein Allergy in Infants and Children: Review the different GI presentaions of CMPA: How to differentiate between types of CMPA: Diagnosis: Management.
The second lecture by Dr. Ravi and Dr. Emad, focused on the Ocular Allergy: Vernal Kerato Conjunctivitis: Atopic Kerato Conjunctivitis: Case Study: 35 yo female postal worker with peanut allergy.
Dr. Emad and Dr. Stuart have discussed Interesting Allergy Cases: Investigations: Treatment: Discussion: The Future medications.
Dr. Stuart explained the day-two agenda, and he introduced the speakers, Dr. Deepa Grandon, Staff Physician, Allergy ＆ Immunology, Respiratory Institute, Cleveland Clinic, Abu Dhabi, UAE, Dr. David Cremonesini, Consultant Paediatrician with a special interest Allergy and Asthma, Mediclinic Parkview Hospital, Dubai, UAE.
Dr. Stuart gave a very illuminating lecture related to Vasomotor Rhinitis – Nothing to Sneeze At: Case Study: 38 yo German Caucasian female with “allergies”: Diagnosis: Treatment.
Dr. Deepa has delivered an in-depth scientific review on Diagnostic Challenges and Desensitization Protocols for NSAID reactions: Why are NSAID reactions challenging to diagnose?: Indications for Desensitization: Choice of NSAIDs and Placebo.
Dr. David has discussed a lecture called GINA Update – SMART Therapy and What We Have Learned from Asthma Deaths: Multidisciplinary confidential enquiry panels: Asthma Deaths – Confidential Enquiries: Why asthma still kills?
Prof. Abuzakouk’s has provided a very comprehensive lecture on Tezepelumab – New Frontiers in Biological Therapies: A Potential Treatment for Epithelial-Driven Diseases: Tezepelumab and Severe Asthma.
As a symposium speaker, Dr. Fulvio Salvo, Consultant Allergy and Clinical Immunology, has presented his topic on a Severe Allergic Asthma Management and role of IgE: Xolair (omalizumab) & effects on early-phase allergic response: Xolair (omalizumab) & effects on late-phase allergic response: Recent developments.
The moderators have conducted the Q&A session and answered all the questions posted in the Q&A box. She expressed his appreciation and gratitude to the speakers, the organizer MCO, the sponsor Novartis, and the attendees for facilitating the webinar.